On May 10 the HIV/AIDS Monitor invited key officials from OGAC/PEPFAR, the Global Fund for ATM, and the World Bank, and an expert on performance based funding (PBF) to discuss ways in which AIDS donors could improve the use of data about performance in their funding decisions.
With contributions from David Wendt.
In 2008, international AIDS assistance from the G-8, European Commission, and other donor governments reached its highest level to date--US $8.7 billion—a greater than fivefold increase from 2002 levels. Despite this increase, it is unlikely that this funding trend will continue in the current global economic downturn.
Related Content
HIV/AIDS Monitor Report: Are Funding Decisions Based on Performance?
CGD Brief: Every Dollar Counts: How Global AIDS Donors Can Better Link Funding Decisions to Performance
As funding becomes more constrained, donors and recipient countries will need to do more and better with the same amount of money—for HIV treatment, prevention and care, health systems strengthening, family planning, maternal and child health and nutrition. This pressure pushes donors to ensure that funding goes only to the most effective programs. How might they do that?
A study by Nirmala Ravishankar and colleagues at Chris Murray’s Institute for Health Metrics and Evaluation (IHME) published today in the Lancet and reported at Forbes and MSNBC gives the most comprehensive estimates yet available of the total amount that people in higher income countries have been spending to t
Over the last few years there have been a series of articles emphasizing how special the price of zero might be for consumers. In 2004 Michael Kremer and Ted Miguel published a CGD working paper (later published in the QJE) showing that eliminating altogether the price parents would have to pay for de-worming medicine for their children had an extraordinarily stimulating effect on uptake compared to even a very small non-zero price.